National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

bevacizumab (beh-vuh-SIH-zoo-mab)

 A monoclonal antibody used in the treatment of colorectal cancer that has spread. It is also being studied in the treatment of other types of cancer. Bevacizumab binds to vascular endothelial growth factor (VEGF) and may prevent the growth of new blood vessels that tumors need to grow. It is a type of antiangiogenesis agent. Also called Avastin.



Previous Definitions:beta hemolytic streptococcus group B, beta-2-microglobulin, beta-endorphin, beta-glucan, beta-human chorionic gonadotropin
Next Definitions:bexarotene, Bexxar regimen, BG00001, BI 2536, BI-RADS

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov